Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T17:08:18.317Z.
Calculation as of: 2026-10-06T17:08:18.317Z.
Quote observation: 2026-10-06T17:05:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 90679ad2ebc726f85ad5a506798b39921ba07a118d770c3f813f824e0087dd78
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-03-28.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
0.65x
EV/FCF RATIO AVG 3Y
2.46x
EV/FCF RATIO AVG 5Y
2.46x
EV/FCF RATIO AVG 10Y
21.26x
EV/FCF RATIO AVG 15Y
21.36x
EV/FCF RATIO AVG 20Y
44.19x
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
OraSure Technologies, Inc.
Market Cap
$265.41M
EV/FCF Ratio
N/A
TTM Avg
0.65x
3Y Avg
2.46x
5Y Avg
2.46x
Market Cap
$264.32M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.84M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$265.36M
EV/FCF Ratio
N/A
TTM Avg
48.59x
3Y Avg
48.59x
5Y Avg
48.59x
Market Cap
$262.19M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$271.89M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OraSure Technologies, Inc. (OSUR) | $265.41M | N/A | 0.65x | 2.46x | 2.46x |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $264.32M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.84M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.36M | N/A | 48.59x | 48.59x | 48.59x |
| Scribe Therapeutics Inc. (SCTX)vs › | $267.65M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $262.19M | N/A | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $261.25M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $259.01M | N/A | 4.58x | 4.76x | 4.76x |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $271.89M | N/A | N/A | N/A | N/A |
| SAB Biotherapeutics, Inc. (SABS)vs › | $272.50M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2025-03-28 | 0.09x |
| 2025-03-27 | 0.28x |
| 2025-03-25 | 0.28x |
| 2025-03-24 | 0.82x |
| 2025-03-21 | 0.12x |
| 2025-03-20 | 0.44x |
| 2025-03-19 | 0.34x |
| 2025-03-18 | 0.19x |
| 2025-03-17 | 0.53x |
| 2025-03-14 | 0.34x |
| 2025-03-13 | 0.03x |
| 2025-03-12 | 0.25x |
| 2025-02-25 | 0.48x |
| 2025-02-24 | 0.47x |
| 2025-02-21 | 0.25x |
| 2025-02-20 | 0.34x |
| 2025-02-19 | 0.41x |
| 2025-02-18 | 0.44x |
| 2025-02-14 | 0.40x |
| 2025-02-13 | 0.35x |
| 2025-02-12 | 0.18x |
| 2025-02-11 | 0.27x |
| 2025-02-10 | 0.32x |
| 2025-02-07 | 0.27x |
| 2025-02-06 | 0.38x |
| 2025-02-05 | 0.47x |
| 2025-02-04 | 0.49x |
| 2025-02-03 | 0.38x |
| 2025-01-31 | 0.51x |
| 2025-01-30 | 0.47x |
| 2025-01-29 | 0.37x |
| 2025-01-28 | 0.38x |
| 2025-01-27 | 0.61x |
| 2025-01-24 | 0.49x |
| 2025-01-23 | 0.47x |
| 2025-01-22 | 0.35x |
| 2025-01-21 | 0.39x |
| 2025-01-17 | 0.07x |
| 2025-01-16 | 0.16x |
| 2025-01-15 | 0.20x |
| 2025-01-14 | 0.10x |
| 2025-01-13 | 0.13x |
| 2025-01-10 | 0.04x |
| 2025-01-08 | 0.14x |
| 2025-01-07 | 0.23x |
| 2025-01-06 | 0.18x |
| 2025-01-03 | 0.12x |
| 2024-12-31 | 0.03x |
| 2024-12-27 | 0.04x |
| 2024-12-26 | 0.06x |
| 2024-12-24 | 0.12x |
| 2024-12-23 | 0.04x |
| 2024-12-20 | 0.06x |
| 2024-12-19 | 0.24x |
| 2024-12-18 | 0.24x |
| 2024-12-17 | 0.33x |
| 2024-12-16 | 0.45x |
| 2024-12-13 | 0.38x |
| 2024-12-12 | 0.58x |
| 2024-12-11 | 0.61x |
| 2024-12-10 | 0.26x |
| 2024-12-09 | 0.44x |
| 2024-12-06 | 0.38x |
| 2024-12-05 | 0.30x |
| 2024-12-04 | 0.33x |
| 2024-12-03 | 0.28x |
| 2024-12-02 | 0.37x |
| 2024-11-29 | 0.25x |
| 2024-11-27 | 0.30x |
| 2024-11-26 | 0.28x |
| 2024-11-25 | 0.40x |
| 2024-11-22 | 0.34x |
| 2024-11-21 | 0.31x |
| 2024-11-20 | 0.26x |
| 2024-11-19 | 0.32x |
| 2024-11-18 | 0.19x |
| 2024-11-15 | 0.31x |
| 2024-11-14 | 0.47x |
| 2024-11-13 | 0.54x |
| 2024-11-12 | 0.65x |
| 2024-11-11 | 0.76x |
| 2024-11-08 | 0.82x |
| 2024-11-07 | 0.76x |
| 2024-11-06 | 0.93x |
| 2024-11-05 | 0.84x |
| 2024-11-04 | 0.78x |
| 2024-11-01 | 0.74x |
| 2024-10-31 | 0.65x |
| 2024-10-30 | 0.76x |
| 2024-10-29 | 0.81x |
| 2024-10-28 | 0.73x |
| 2024-10-25 | 0.62x |
| 2024-10-24 | 0.62x |
| 2024-10-23 | 0.66x |
| 2024-10-22 | 0.67x |
| 2024-10-21 | 0.68x |
| 2024-10-18 | 0.72x |
| 2024-10-17 | 0.65x |
| 2024-10-16 | 0.65x |
| 2024-10-15 | 0.62x |
| 2024-10-14 | 0.63x |
| 2024-10-11 | 0.68x |
| 2024-10-10 | 0.61x |
| 2024-10-09 | 0.66x |
| 2024-10-08 | 0.67x |
| 2024-10-07 | 0.67x |
| 2024-10-04 | 0.71x |
| 2024-10-03 | 0.66x |
| 2024-10-02 | 0.72x |
| 2024-10-01 | 0.74x |
| 2024-09-30 | 0.82x |
| 2024-09-27 | 0.84x |
| 2024-09-26 | 0.81x |
| 2024-09-25 | 0.77x |
| 2024-09-24 | 0.85x |
| 2024-09-23 | 0.94x |
| 2024-09-20 | 0.87x |
| 2024-09-19 | 0.89x |
| 2024-09-18 | 0.86x |
| 2024-09-17 | 0.93x |
| 2024-09-16 | 0.93x |
| 2024-09-13 | 0.98x |
| 2024-09-12 | 0.81x |
| 2024-09-11 | 0.81x |
| 2024-09-10 | 0.77x |
| 2024-09-09 | 0.77x |
| 2024-09-06 | 0.69x |
| 2024-09-05 | 0.99x |
| 2024-09-04 | 0.92x |
| 2024-09-03 | 0.91x |
| 2024-08-30 | 1.00x |
| 2024-08-29 | 1.05x |
| 2024-08-28 | 0.89x |
| 2024-08-27 | 0.92x |
| 2024-08-26 | 0.92x |
| 2024-08-23 | 0.97x |
| 2024-08-22 | 0.79x |
| 2024-08-21 | 0.84x |
| 2024-08-20 | 0.80x |
| 2024-08-19 | 0.82x |
| 2024-08-16 | 0.75x |
| 2024-08-15 | 0.69x |
| 2024-08-14 | 0.62x |
| 2024-08-13 | 0.73x |
| 2024-08-12 | 0.69x |
| 2024-08-09 | 0.78x |
| 2024-08-08 | 1.10x |
| 2024-08-07 | 0.88x |
| 2024-08-06 | 0.63x |
| 2024-08-05 | 0.59x |
| 2024-08-02 | 0.63x |
| 2024-08-01 | 0.74x |
| 2024-07-31 | 0.72x |
| 2024-07-30 | 0.71x |
| 2024-07-29 | 0.65x |
| 2024-07-26 | 0.63x |
| 2024-07-25 | 0.67x |
| 2024-07-24 | 0.65x |
| 2024-07-23 | 0.64x |
| 2024-07-22 | 0.66x |
| 2024-07-19 | 0.57x |
| 2024-07-18 | 0.59x |
| 2024-07-17 | 0.71x |
| 2024-07-16 | 0.77x |
| 2024-07-15 | 0.62x |
| 2024-07-12 | 0.62x |
| 2024-07-11 | 0.62x |
| 2024-07-10 | 0.56x |
| 2024-07-09 | 0.51x |
| 2024-07-08 | 0.51x |
| 2024-07-05 | 0.42x |
| 2024-07-03 | 0.48x |
| 2024-07-02 | 0.50x |
| 2024-07-01 | 0.61x |
| 2024-06-28 | 0.60x |
| 2024-06-27 | 0.58x |
| 2024-06-26 | 0.57x |
| 2024-06-25 | 0.58x |
| 2024-06-24 | 0.61x |
| 2024-06-21 | 0.68x |
| 2024-06-20 | 0.76x |
| 2024-06-18 | 0.60x |
| 2024-06-17 | 0.61x |
| 2024-06-14 | 0.69x |
| 2024-06-13 | 0.62x |
| 2024-06-12 | 0.75x |
| 2024-06-11 | 0.73x |
| 2024-06-10 | 0.79x |
| 2024-06-07 | 0.84x |
| 2024-06-06 | 0.92x |
| 2024-06-05 | 0.92x |
| 2024-06-04 | 0.82x |
| 2024-06-03 | 0.85x |
| 2024-05-31 | 0.86x |
| 2024-05-30 | 0.84x |
| 2024-05-29 | 0.83x |
| 2024-05-28 | 0.92x |
| 2024-05-24 | 0.93x |
| 2024-05-23 | 0.96x |
| 2024-05-22 | 1.04x |
| 2024-05-21 | 0.95x |
| 2024-05-20 | 0.97x |
| 2024-05-17 | 0.96x |
| 2024-05-16 | 1.14x |
| 2024-05-15 | 1.22x |
| 2024-05-14 | 1.26x |
| 2024-05-13 | 1.10x |
| 2024-05-10 | 0.93x |
| 2024-05-09 | 0.78x |
| 2024-05-08 | 0.92x |
| 2024-05-07 | 1.06x |
| 2024-05-06 | 1.03x |
| 2024-05-03 | 1.03x |
| 2024-05-02 | 1.02x |
| 2024-05-01 | 0.94x |
| 2024-04-30 | 0.91x |
| 2024-04-29 | 0.98x |
| 2024-04-26 | 0.93x |
| 2024-04-25 | 0.90x |
| 2024-04-24 | 1.03x |
| 2024-04-23 | 1.05x |
| 2024-04-22 | 0.95x |
| 2024-04-19 | 0.91x |
| 2024-04-18 | 0.89x |
| 2024-04-17 | 0.89x |
| 2024-04-16 | 0.87x |
| 2024-04-15 | 0.98x |
| 2024-04-12 | 1.04x |
| 2024-04-11 | 1.19x |
| 2024-04-10 | 1.20x |
| 2024-04-09 | 1.28x |
| 2024-04-08 | 1.27x |
| 2024-04-05 | 1.30x |
| 2024-04-04 | 1.32x |
| 2024-04-03 | 1.42x |
| 2024-04-02 | 1.32x |
| 2024-04-01 | 1.36x |
| 2024-03-28 | 1.40x |
| 2024-03-27 | 1.40x |
| 2024-03-26 | 1.36x |
| 2024-03-25 | 1.44x |
| 2024-03-22 | 1.50x |
| 2024-03-21 | 1.51x |
| 2024-03-20 | 1.62x |
| 2024-03-19 | 1.74x |
| 2024-03-18 | 1.78x |
| 2024-03-15 | 1.69x |
| 2024-03-14 | 1.82x |
| 2024-03-13 | 1.91x |
| 2024-03-12 | 1.92x |
| 2024-03-11 | 4.43x |
| 2024-03-08 | 4.77x |
| 2024-03-07 | 4.83x |
| 2024-03-06 | 4.49x |
| 2024-03-05 | 4.52x |
| 2024-03-04 | 4.41x |
| 2024-03-01 | 4.81x |
| 2024-02-29 | 4.73x |
| 2024-02-28 | 5.29x |
| 2024-02-27 | 4.55x |
Showing the most recent 260 of 2,915 data points. The chart above shows the full history.
